Recital 10, Regulation (EU) 2016/871

In forcesince 1 Jun 2016

Additionally, amitrole is classified in accordance with Regulation (EC) No 1272/2008 of the European Parliament and of the Council [Regulation (EC) No 1272/2008 of the European Parliament and of the Council of 16 December 2008 on classification, labelling and packaging of substances and mixtures, amending and repealing Directives 67/548/EEC and 1999/45/EC, and amending Regulation (EC) No 1907/2006 (OJ L 353, 31.12.2008, p. 1).] as toxic for reproduction category 2 and it has toxic effects on endocrine organs. Therefore, and taking into account the conclusion of the Authority, amitrole should be considered to have endocrine disrupting properties pursuant to the interim provisions of the fourth paragraph of point 3.6.5 of Annex II to Regulation (EC) No 1107/2009. However, given that the identified risks referred to in recital 8 preclude approval of amitrole, it was not appropriate to consider whether exposure to amitrole under realistic proposed conditions of use is negligible. Therefore, it could not be concluded whether amitrole meets the approval criteria related to endocrine disrupting properties as outlined in the first paragraph of point 3.6.5 of Annex II to Regulation (EC) No 1107/2009.